ArticleKidney medicine2025
Primary Ewing Sarcoma Within an Autosomal Dominant Polycystic Kidney: A Case Report.
Article in Kidney medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ewing sarcoma, that originates from neuroectoderm, is typically encountered in the bone and soft tissue of children and young adults and rarely presents as a primary renal tumor. Autosomal dominant polycystic kidney disease, which is the most common type of inherited kidney disease, has been debated to be associated with an increased risk of kidney cancer. This report describes the first documented case of primary Ewing sarcoma arising within an autosomal dominant polycystic kidney. A 44-year-old male with end-stage kidney disease secondary to autosomal dominant polycystic kidney disease presented with left flank pain. Imaging revealed a 14 cm heterogeneous mass in the lower pole of the polycystic left kidney. The patient underwent laparoscopic left nephrectomy, and pathology examination confirmed the diagnosis of primary Ewing sarcoma. He received 12 cycles of adjuvant chemotherapy, including vincristine, dactinomycin, and cyclophosphamide. Despite treatment, disease relapse occurred 13 months after the initial diagnosis, and the patient died 3 months later. Primary Ewing sarcoma of the kidney is a rare malignancy with nonspecific clinical and imaging features. It is associated with a poor prognosis due to delayed diagnosis, high metastatic potential, and frequent recurrence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.